{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:43:51Z","timestamp":1791438231378,"version":"4.3.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.neurobiolaging.2012.01.110","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T15:01:02Z","timestamp":1331132462000},"page":"1846.e7-1846.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Implication of common and disease specific variants in CLU, CR1, and PICALM"],"prefix":"10.1016","volume":"33","author":[{"given":"Raffaele","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge H.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu T.","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid E.","family":"O'Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan S.","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Momeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib1a","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/excr.2001.5358","article-title":"Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes","volume":"271","author":"Bartl","year":"2001","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00439-010-0924-2","article-title":"Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease","volume":"129","author":"Belbin","year":"2011","journal-title":"Hum. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system J","volume":"27","author":"Bell","year":"2007","journal-title":"Cereb. Blood Flow Metab"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A new and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"17","author":"Brouwers","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib7","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1523\/JNEUROSCI.2471-08.2008","article-title":"Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons","volume":"28","author":"Bushlin","year":"2008","journal-title":"Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","article-title":"Apolipoprotein J (clusterin) and Alzheimer's disease","volume":"50","author":"Calero","year":"2000","journal-title":"Micro. Res. Technol"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib10","doi-asserted-by":"crossref","unstructured":"Carrasquillo, M.M., Belbin, O., Hunter, T.A., Ma, L., Bisceglio, G.D., Zou, F., Crook, J.E., Pankratz, V.S., Dickson, D.W., Graff-Radford, N.R., Petersen, R.C., Morgan, K., Younkin, S.G. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch. Neurol. 67, 961\u2013964.","DOI":"10.1001\/archneurol.2010.147"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib12","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","article-title":"Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals","volume":"19","author":"Corneveaux","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib13","doi-asserted-by":"crossref","first-page":"13240","DOI":"10.1016\/S0021-9258(19)38290-0","article-title":"A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins","volume":"265","author":"de Silva","year":"1990","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.134.3.1787","article-title":"Polymorphism of the C3b\/C4b receptor (CR1): characterization of a fourth allele","volume":"134","author":"Dykman","year":"1985","journal-title":"J. Immunol"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1786","article-title":"Life of a clathrin coat: insights from clathrin and AP structures","volume":"7","author":"Edeling","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj3310231","article-title":"Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?","volume":"331","author":"Gelissen","year":"1998","journal-title":"Biochem. J"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib17","doi-asserted-by":"crossref","first-page":"e9510","DOI":"10.1371\/journal.pone.0009510","article-title":"Genetic variability in CLU and its association with Alzheimer's disease","volume":"5","author":"Guerreiro","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib19","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1073\/pnas.84.8.2459","article-title":"Human complement C3b\/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism","volume":"84","author":"Holers","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib20","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib23","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.neurobiolaging.2010.11.022","article-title":"Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations","volume":"32","author":"Lambert","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"Lucin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib26","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1074\/jbc.270.13.7563","article-title":"Characterization of apolipoprotein J-Alzheimer's A beta interaction","volume":"270","author":"Matsubara","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(92)90071-G","article-title":"Distribution of clusterin in Alzheimer brain tissue","volume":"579","author":"McGeer","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib28","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.neurobiolaging.2010.07.016","article-title":"Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old","volume":"32","author":"Mengel-From","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3280045","article-title":"Stress-induced transcription of the clusterin\/apoJ gene","volume":"328","author":"Michel","year":"1997","journal-title":"Biochem. J"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","article-title":"Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms","volume":"48","author":"Nilselid","year":"2006","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0021-9258(18)54194-6","article-title":"Identification of the Alzheimer beta\/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells","volume":"268","author":"Nordstedt","year":"1993","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib33","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib34","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1600-0854.2010.01104.x","article-title":"Clathrin-mediated endocytosis at the synaptic terminal: bridging the gap between physiology and molecules","volume":"11","author":"Royle","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib35","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib36","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.1996.tb32593.x","article-title":"Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease","volume":"802","author":"Tang","year":"1996","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib38","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1091\/mbc.10.8.2687","article-title":"Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic","volume":"10","author":"Tebar","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrm2751","article-title":"Tickets to ride: selecting cargo for clathrin-regulated internalization","volume":"10","author":"Traub","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib40","first-page":"9","volume":"60","author":"Waring","year":"2008","journal-title":"Texas Public Health Journal, Special Issue on the Texas Alzheimer's Research Consortium"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib41","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1084\/jem.164.5.1531","article-title":"Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I","volume":"164","author":"Wong","year":"1986","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib42","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice Proc","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib43","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","article-title":"Complement activation in very early Alzheimer disease Alzheimer","volume":"19","author":"Zanjani","year":"2005","journal-title":"Dis. Assoc. Disord"},{"key":"10.1016\/j.neurobiolaging.2012.01.110_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt24","article-title":"Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy","volume":"2","author":"Zotova","year":"2010","journal-title":"Alzheimers Res. Ther"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:19:13Z","timestamp":1759317553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0197458012001315"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.01.110","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of common and disease specific variants in CLU, CR1, and PICALM","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.01.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}